T1	Participants 54 103	patients with advanced non-small-cell lung cancer
T2	Participants 284 321	metastatic non-small-cell lung cancer
T3	Participants 1269 1301	37 pts (88%) in the DCT/CDDP arm
T4	Participants 1306 1338	39 pts (87%) in the VNR/CDDP one
T5	Participants 2762 2806	pts with advanced non-small-cell lung cancer
